Magistrate Rules On Motions In Crestor Patent MDL

Law360, New York (November 25, 2008, 12:00 AM EST) -- A magistrate judge on Monday recommended a mix of pretrial rulings as plaintiff AstraZeneca Pharmaceuticals LP sought to defend the patent for its multibillion-dollar drug Crestor against multiple generic-drug makers.

Each of nine defendants in the U.S. District Court for the District of Delaware is involved in some way with the filing of an abbreviated new drug application with the U.S. Food and Drug Administration. The defendants are seeking to manufacture, import, use or sell generic versions of Crestor.

In December 2007, soon after it received...
To view the full article, register now.